浙江医学
浙江醫學
절강의학
ZHEJIANG MEDICAL JOURNAL
2013年
23期
2083-2086
,共4页
朱丞%王奕權%曹阳光%陈致宇
硃丞%王奕權%曹暘光%陳緻宇
주승%왕혁권%조양광%진치우
精神分裂症%抗精神病药%转归%随访
精神分裂癥%抗精神病藥%轉歸%隨訪
정신분렬증%항정신병약%전귀%수방
Schizophrenia%Antipsychotic drugs%Outcome%Follow up
目的:比较经典与非经典抗精神病药物长期维持治疗对精神分裂症患者转归的影响。方法选择255例出院的精神分裂症患者,依据其出院后1个月且病情稳定时服用的治疗药物,分为经典抗精神病药物治疗组(经典组)和非经典抗精神病药物治疗组(非经典组),进行为期2年的随访观察。分别用阳性及阴性症状量表(PANSS)、生活质量量表(SQOL)、个人和社会功能量表(PSP)和不良反应量表(TESS)评估患者的症状、生活质量、社会功能及药物不良反应。结果与基线期相比,经典组与非经典组患者在随访2年时PANSS评分及SQOL评分均显著下降;但两组间PANSS及SQOL评分差值的差异均无统计学意义。与基线期相比,在随访2年时,经典组患者PSP评分与基线期的差异无统计学意义;而非经典组患者PSP评分较基线期均有显著性提高;且两组之间PSP评分差值的差异有统计学意义。非经典组体重增加的发生率显著高于经典组。结论精神分裂症患者长期服用非经典抗精神病药物维持治疗,疗效与经典抗精神病药物相当,并且药物不良反应更少,能够获得更好的生活质量及社会功能。
目的:比較經典與非經典抗精神病藥物長期維持治療對精神分裂癥患者轉歸的影響。方法選擇255例齣院的精神分裂癥患者,依據其齣院後1箇月且病情穩定時服用的治療藥物,分為經典抗精神病藥物治療組(經典組)和非經典抗精神病藥物治療組(非經典組),進行為期2年的隨訪觀察。分彆用暘性及陰性癥狀量錶(PANSS)、生活質量量錶(SQOL)、箇人和社會功能量錶(PSP)和不良反應量錶(TESS)評估患者的癥狀、生活質量、社會功能及藥物不良反應。結果與基線期相比,經典組與非經典組患者在隨訪2年時PANSS評分及SQOL評分均顯著下降;但兩組間PANSS及SQOL評分差值的差異均無統計學意義。與基線期相比,在隨訪2年時,經典組患者PSP評分與基線期的差異無統計學意義;而非經典組患者PSP評分較基線期均有顯著性提高;且兩組之間PSP評分差值的差異有統計學意義。非經典組體重增加的髮生率顯著高于經典組。結論精神分裂癥患者長期服用非經典抗精神病藥物維持治療,療效與經典抗精神病藥物相噹,併且藥物不良反應更少,能夠穫得更好的生活質量及社會功能。
목적:비교경전여비경전항정신병약물장기유지치료대정신분렬증환자전귀적영향。방법선택255례출원적정신분렬증환자,의거기출원후1개월차병정은정시복용적치료약물,분위경전항정신병약물치료조(경전조)화비경전항정신병약물치료조(비경전조),진행위기2년적수방관찰。분별용양성급음성증상량표(PANSS)、생활질량량표(SQOL)、개인화사회공능량표(PSP)화불량반응량표(TESS)평고환자적증상、생활질량、사회공능급약물불량반응。결과여기선기상비,경전조여비경전조환자재수방2년시PANSS평분급SQOL평분균현저하강;단량조간PANSS급SQOL평분차치적차이균무통계학의의。여기선기상비,재수방2년시,경전조환자PSP평분여기선기적차이무통계학의의;이비경전조환자PSP평분교기선기균유현저성제고;차량조지간PSP평분차치적차이유통계학의의。비경전조체중증가적발생솔현저고우경전조。결론정신분렬증환자장기복용비경전항정신병약물유지치료,료효여경전항정신병약물상당,병차약물불량반응경소,능구획득경호적생활질량급사회공능。
Objective To compare the effects of typical and atypical antipsychotic maintenance treatment on outcome in patients with schizophrenia. Methods A total of 255 inpatients included from June 2009 to September 2011 were divided into two groups:the typical antipsychotics group(Typical Group) and the atypical antipsychotics group(Atypical Group) according to the drugs they took a month after discharge from hospital and in stable condition. Symptoms, quality of life, social function and adverse reaction of al patients were assessed with the Positive and Negative Symptoms scale (PANSS), the Self- report quality of life scale (SQOL), the Personal and Social performance scale (PSP), and the Treatment Emergent Symptom Scale (TESS) at baseline, half a year, one and two years after. Results At the end of the fol ow up, the atypical group's total PSP scores were significantly higher than typical group;the total PANSS score and the total SQOL score of atypical group were lower than typical group, but there was no statistical significance. Among adverse reactions, only weight gain was significantly higher in atypical group than in typical group. Conclusion The atypical antipsychotics are not only as effective as typical antipsychotics in main-tance therapy of schizophrenic, but also has better quality of life and social function, and less adverse reactions than typical an-tipsychotic.